Analyst Reco. CureVac N.V.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:50:00 2025-07-10 pm EDT			5-day change	1st Jan Change
5.455 ^USD	-0.82%		+0.09%	+59.97%

Jul. 01	CureVac N.V. - Shareholder/Analyst Call
Jun. 26	UBS Downgrades CureVac to Neutral From Buy, Adjusts Price Target to $5.50 From $12	MT

UBS Downgrades CureVac to Neutral From Buy, Adjusts Price Target to $5.50 From $12	Jun. 26	MT
Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target	Jun. 13	MT
CUREVAC : Downgraded to Neutral by Jefferies	Jun. 13	ZD
CUREVAC : Successful cash burn reduction	Jun. 01
UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating	Apr. 30	MT
CUREVAC : 2025 will be less costly	Apr. 11
CUREVAC : The mid-term effect of pipeline pruning	Feb. 21
CUREVAC : Licensing deal boosts bank account	Dec. 12
CUREVAC : Positive one-off overshadows pipeline dryness	Dec. 08
CUREVAC : Deutsche Bank reiterates its Neutral rating	24-09-02	ZD
CUREVAC : A beneficial deal	24-08-31
CUREVAC : Much noise at CureVac, overshadowing recent positive pipeline progress	24-08-20
CUREVAC : Significant cash drain in the Q1	24-05-23
CUREVAC : A missed opportunity	24-05-02
UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating	24-04-26	MT
Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4	24-04-25	MT
Kempen Upgrades CureVac to Buy From Neutral, Price Target is $10	23-12-22	MT
CUREVAC : An untrimmed pipeline becomes costly	23-11-29
CUREVAC : Unchanged cash drain	23-11-28
CUREVAC : A missed opportunity	23-08-21
CUREVAC : Higher losses expected in future	23-07-25
CUREVAC : Some glimpse of positive pipeline developments	23-06-21
SVB Securities Initiates CureVac at Outperform With $13 Price Target	23-06-08	MT
CUREVAC : Runway prolonged	23-05-30
CUREVAC : One big point despite many misses	23-05-02

No results for this search

CUREVAC : Successful cash burn reduction

June 01, 2025 at 10:14 am EDT